Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

Lancet

Volumn 358, Issue 9276, 2001, Pages 121-122

  Chan, Raymond C ^a   Penney, David J ^b   Little, Dianne ^c   Carter, Ian W ^d   Roberts, Jason A ^d   Rawlinson, William D ^d  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

^c Institute of Clinical Pathology and Medical Research NSW Health Pathology   (Australia)

^d New South Wales Government   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CEFTRIAXONE; MENINGOCOCCUS VACCINE; ROXITHROMYCIN; YELLOW FEVER VACCINE;

3' UNTRANSLATED REGION; ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; DEATH; DNA SEQUENCE; DRUG INDICATION; DRUG SAFETY; DRUG USE; FEVER; HEPATITIS; HUMAN; MALE; MYALGIA; NAUSEA AND VOMITING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VACCINATION; VIRUS ISOLATION; VIRUS MUTATION; VIRUS STRAIN; VIRUS VIRULENCE; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS;

EID: 0035859475     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)05341-7     Document Type: Article

References (4)

1. Yellow fever vaccine. Recommendations of the Immunization Practices Advisory Committee
2. Fatal viral encephalitis following 17D yellow fever vaccine inoculation: Report of case in a 3-year old child; a joint statement
3. Identification of mosquito-borne Flavivirus sequences using universal primers and reverse transcription/polymerase chain reaction
4. Simplified hepatitis C virus genotyping by heteroduplex mobility analysis